公开(公告)号：US20080107609A1

公开(公告)日：2008-05-08

申请号：US11850509

申请日：2007-09-05

Applicant: Francis Cuss ,  Keith Nolop ,  Ulo Palm ,  Heribert Staudinger

Inventor： Francis Cuss ,  Keith Nolop ,  Ulo Palm ,  Heribert Staudinger

IPC: A61K9/14 ,  A61K31/58 ,  A61P11/00

CPC classification number: A61K9/0075 ,  A61K31/56 ,  A61K31/58

Abstract: The invention relates to treating chronic obstructive pulmonary disease, involving the administration by inhalation of mometasone furoate particles in daily doses where at least about 250 μg of the inhaled particles have sizes equal to or less than 6.5 μm.

Abstract translation: 本发明涉及治疗慢性阻塞性肺疾病，涉及以日剂量吸入糠酸莫米他松颗粒给药，其中至少约250杯吸入颗粒具有等于或小于6.5微米的尺寸。

公开(公告)号：US20050287080A1

公开(公告)日：2005-12-29

申请号：US11210409

申请日：2005-08-24

Applicant: Joel Sequeira ,  Francis Cuss ,  Keith Nolop ,  Imtiaz Chaudry ,  Nagamani Nagabhushan ,  James Patrick ,  Mitchell Cayen

Inventor： Joel Sequeira ,  Francis Cuss ,  Keith Nolop ,  Imtiaz Chaudry ,  Nagamani Nagabhushan ,  James Patrick ,  Mitchell Cayen

IPC: A61K9/00 ,  A61K9/14 ,  A61K31/57 ,  A61K31/58 ,  A61L9/04

CPC classification number: A61K9/008 ,  A61K9/0043 ,  A61K9/0075 ,  A61K31/57 ,  A61K31/58 ,  Y10S514/826 ,  Y10S514/828 ,  Y10S514/958

Abstract: The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.

Abstract translation: 公开了用于治疗上呼吸道和/或下气道通道和/或肺的表面（例如过敏性鼻炎和哮喘）的皮质类固醇反应性疾病的干燥粉末，溶液或水悬浮液形式的糠酸莫米他的雾化颗粒的雾化颗粒，例如过敏性鼻炎和哮喘 。

公开(公告)号：US20050148563A1

公开(公告)日：2005-07-07

申请号：US10948987

申请日：2004-09-24

Applicant: Francis Cuss ,  Keith Nolop ,  Ulo Palm ,  Heribert Staudinger

Inventor： Francis Cuss ,  Keith Nolop ,  Ulo Palm ,  Heribert Staudinger

IPC: A61K9/00 ,  A61K31/56 ,  A61K31/58 ,  A61P11/06 ,  A61P11/08 ,  A61K9/14 ,  A61L9/04

CPC classification number: A61K9/0075 ,  A61K31/56 ,  A61K31/58

Abstract: The invention relates to treating chronic obstructive pulmonary disease, involving the administration by inhalation of mometasone furoate particles in daily doses where at least about 250 μg of the inhaled particles have sizes equal to or less than 6.5 μm.

Abstract translation: 本发明涉及治疗慢性阻塞性肺疾病，涉及以日剂量吸入糠酸莫米他松颗粒给药，其中至少约250杯吸入颗粒具有等于或小于6.5微米的尺寸。